Full year 2025 total revenues increased by 27% to US$376.1 million, driven by continued growth of RUCONEST and rising demand for Joenja (leniolisib) Fourth quarter 2025 total revenues increased by 15% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results